Geoffrey Berguig

Geoffrey Berguig currently serves as the Chief Scientific Officer at Evercrisp Biosciences since September 2022, focusing on genome editing for high-confidence, genetically validated targets in healthcare. Prior to this role, Geoffrey held various positions at BioMarin Pharmaceutical Inc. from September 2014 to September 2022, including Director of Chemistry and Drug Delivery, where responsibilities included leading the Delivery Group and collaborating with business development. Geoffrey's early career includes significant research and academic roles, such as Postdoctoral Research Fellow at the University of Washington, where work on biologic drug conjugates was conducted, and earlier positions at prestigious institutions like the University of Washington and Georgia Institute of Technology. Geoffrey holds a Ph.D. in Bioengineering from the University of Washington and a BS in Mechanical Engineering from Georgia Institute of Technology.